ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,521 | -25.7% | 14,757 | -1.4% | 0.08% | -23.3% |
| Q2 2023 | $533,902 | +4.8% | 14,972 | -25.4% | 0.10% | -2.8% |
| Q1 2023 | $509,549 | -39.1% | 20,061 | -2.7% | 0.11% | -44.8% |
| Q4 2022 | $836,591 | -8.4% | 20,626 | -25.3% | 0.19% | -11.5% |
| Q3 2022 | $913,000 | -30.6% | 27,626 | -6.8% | 0.22% | -21.4% |
| Q2 2022 | $1,315,000 | -4.8% | 29,646 | -1.3% | 0.28% | -3.8% |
| Q1 2022 | $1,382,000 | -12.5% | 30,051 | +1.2% | 0.29% | -13.0% |
| Q4 2021 | $1,580,000 | -1.2% | 29,693 | +15.9% | 0.33% | -8.8% |
| Q3 2021 | $1,599,000 | +94.1% | 25,611 | +157.5% | 0.36% | +92.6% |
| Q2 2021 | $824,000 | +41.1% | 9,945 | +15.5% | 0.19% | +33.3% |
| Q1 2021 | $584,000 | – | 8,610 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |